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Objective. To identify modiiable cardio-metabolic and lifestyle risk factors among indigenous populations from Australia
(Aboriginal Australians/Torres Strait Islanders), New Zealand (Ma¯ori), and the United States (American Indians and Alaska
Natives) that contribute to cardiovascular disease (CVD). Methods. National health surveys were identiied where available.
Electronic databases identiied sources for illing missing data. he most relevant data were identiied, organized, and synthesized.
Results. Compared to their non-indigenous counterparts, indigenous populations exhibit lower life expectancies and a greater
prevalence of CVD. All indigenous populations have higher rates of obesity and diabetes, hypertension is greater for Ma¯ori and
Aboriginal Australians, and high cholesterol is greater only among American Indians/AlaskaNatives. In turn, all indigenous groups
exhibit higher rates of smoking and dangerous alcohol behaviour as well as consuming less fruits and vegetables. Aboriginal
Australians and American Indians/Alaska Natives also exhibit greater rates of sedentary behaviour. Conclusion. Indigenous groups
fromAustralia, New Zealand, and theUnited States have a lower life expectancy then their respective non-indigenous counterparts.
A higher prevalence of CVD is a major driving force behind this discrepancy. A cluster of modiiable cardio-metabolic risk factors
precede CVD, which, in turn, is linked to modiiable lifestyle risk factors.
1. Introduction
Cardiovascular disease (CVD) is considered the primary
inluencing factor in the life expectancy discrepancy between
indigenous and nonindigenous groups in many countries
[1]. Preceding CVD, many groups exhibit a cluster of car-
diometabolic risk factors, which, in turn, is linked with a
number of modiiable lifestyle risk factors (Figure 1). Mul-
tiple studies have revealed that modiiable risk factors are
responsible for a large number of premature deaths due
to CVD [2, 3]. Recently, it was reported that the single
largest risk factor for cardiovascular mortality in the US
was high blood pressure, directly responsible for 45% of all
CVD deaths, closely followed by obesity, physical inactivity,
high cholesterol, and smoking [2]. Fortunately, many of
these metabolic and lifestyle risk factors are modiiable and
relatively simple to monitor.
he current review will focus on known modiiable
cardio-metabolic (overweight obesity, diabetes, high choles-
terol, and high blood pressure; see Table 1) and common
lifestyle (physical inactivity, poor nutrition, dangerous alcohol
behaviour, and cigarette smoking; see Table 2) risk factors
among indigenous populations fromAustralia, NewZealand,
and the United States. Comparisons will be made with
nonindigenous groups, and discussion will focus on the
association of lifestyle factors and cardiovascular-metabolic
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Table 1: Prevalence of cardio-metabolic risk factors among adults.
Group
Population
Life expect.
yrs
CVD Body weight
High cholest.
%
HT
References
million %
Prev.
%
Mortality
%
Over
%
Obese
%
Diabetes
%
%
AU 20.8 100 81 17 9 29 22 4 7 10
White AU 20.3 98 81 17 9 29 22 4 7 10 [13, 114, 115]
Indigenous AU 0.52 2.5 62 22 27 35 27 12 6 15
NZ 4.03 100 80 5 31 36 27 5 8 14
White NZ 2.61 68 81 4 32 32 24 4 8 13
[6, 14, 16, 26,
116]
Indigenous NZ 0.57 15 73 7 32 32 42 8 9 17
U.S. 309 100 78 21 34 33 33 8 16 34
White U.S. 309 100 78 21 34 33 31 6 17 33
[7, 17, 19, 54,
107]
Indigenous U.S. 5.22 1.7 75 23 25 28 42 15 31 30
CVD: cardiovascular disease; HT: Hypertension.
Notes: a body mass index (BMI) ≥ 25.0 kg/m2 is considered overweight, ≥30.0 kg/m2 is considered obese.
AU: CVD, cholesterol, diabetes (includes high sugar levels), and body weight data are self-reported and age-adjusted for adults ≥ 18 yrs [13].
NZ: diabetes = physician diagnosed; high cholesterol: individuals medicated for high total cholesterol [26]; HT = currently taking prescribed blood pressure
medication [26]; HT, cholesterol, diabetes, and body weight data are for adults aged ≥ 15 [26]; CVD data are age-adjusted for adults ≥18 [14, 16].
US: diabetes = physician diagnosed; high cholesterol = ≥240mg/dL [17]; HT = deined as SBP ≥ 140mmHg and/or DBP ≥ 90mmHg, use of antihypertensive
medication, or physician diagnosed [17]; CVD, hypertension, diabetes, and body weight data are age-adjusted for adults ≥20 [17].
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Figure 1: Causation pathway for cardiovascular disease (CVD) [4].
conditions. Recommendations will be provided for measur-
ing and tracking each of these risk factors.
2. Methods
2.1. Data Sources. Electronic databases included PubMed,
Medline, and Google Scholar. All titles were exported to
Endnote and checked for duplicates.
2.2. Study Inclusion and Exclusion Criteria. National health
surveys were identiied where available. Electronic databases
identiied sources for illing missing data. Criteria for inclu-
sion of articles included (a) published in a peer-reviewed
English-language journal or government report; (b) con-
tained data from nonindigenous cohorts for use as a com-
parison group; (c) cited in health science, nursing, medical,
or exercise science literature. he largest sample studies
containing data for CVD prevalence and mortality published
between 2002 and July 2012 were selected to compare data of
CVD and lifestyle risk factors and conditions (Tables 1 and 2).
2.3. Data Extraction and Data Synthesis. Search terms
included Aboriginal Australians, Ma¯ori, American Indi-
ans/Alaska Natives, indigenous, cardiovascular disease, heart
disease, overweight, obesity, diabetes, cholesterol, blood
pressure, hypertension, alcohol, physical activity, exercise,
nutrition, cigarette smoking, and tobacco.
3. Demographics
3.1. Australia. For the purpose of this paper, the term
indigenous Australian refers to those of Aboriginal origin
and Torres Strait Islanders. he indigenous population is
estimated to be 2.5% of the total Australian population,
approximately 90% of which self identify as Aboriginal, 6% as
Torres Strait Islander, and 4% bothmixed [5].he indigenous
population is relatively young, with amedian age of 20.5 years
compared to 36.6 years for the nonindigenous population
[5]. Around 26% of indigenous people live in remote areas,
compared with only 2% nonindigenous peoples [5], and
many continue to maintain a strong connection to their
traditional culture, language, and lands.
3.2. New Zealand. For the purpose of this paper, the term
indigenous New Zealander encompasses those of Ma¯ori
descent. Ma¯ori people comprise 15% of the total population
[6], with the predominance (84.4%) residing in urban areas
[6]. he Ma¯ori population has a median age of 22.7 years
compared to 35.9 years for the nonindigenous population [6].
Ma¯ori culture continues to be an important thread of New
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Table 2: Prevalence of modiiable lifestyle risk factors.
Group
Activity behaviour Nutrition Alcohol behaviour Smokers
%
References
Sedentary
%
Prescribed
%
Veg.
% ≥2 day
Fruit
% ≥2 day
Any
%
Risky
%
AU 33 33 78 52 83 14 21
White AU 33 33 78 52 83 14 21 [13]
Indigenous AU 51 21 43 26 49 15 46
New Zealand 15 51 64 60 85 13 20
White NZ 14 51 67 63 90 12 19 [26, 81]
Indigenous NZ 14 51 62 56 85 24 38
U.S. 39 11 23 55 7 21
White U.S. 37 12 N/A 60 8 22 [10, 17, 82, 107]
Indigenous U.S. 40 10 17 48 12 24
AU: sedentary activity behavior =<50mins/week,moderate:>800mins/week, for adults≥15 yrs [13]; risky alcohol behavior =≥ 5 standard drinks/day formales
(or ≥15/week) and ≥4 for females (or ≥8/week) for adults aged ≥ 18 yrs [13]; smoker: any type of tobacco consumption [13]; smoking, activity and nutrition
data are age-adjusted for adults ≥18 yrs [13].
NZ: prescribed activity behavior = recommended ≥30mins/day most days or at least 150mins/week, sedentary activity behavior = <30mins/week [26]; risky
alcohol behavior = weekly binge (≥6 standard drinks on one occasion for males and ≥4 for females) drinking, age-adjusted for adults aged 16–64 [81]; smoker
= cigarette smoking [26]; vegetable = ≥3 servings/day [26]; smoking, activity and nutrition date are age-adjusted for adults aged 16–64 [26].
US: prescribed activity behavior =≥30mins/daymost days or at least 150mins/week (self-reported,≥18 yrs), age-adjusted for adults aged≥18 yrs [107]; nutrition
= ≥5 servings/day of vegetables/fruit, age-adjusted for adults aged ≥18 yrs [10]; risky alcohol behaviour = ≥ 5 standard drinks/day on ≥5 days in past 30 days
[82]; smoking = cigarette smoking, age-adjusted for adults aged ≥20 [107].
Zealand society with 23.7% of Ma¯ori being able to hold a
conversation in te Reo Ma¯ori [6].
3.3. United States. For the purpose of this paper, the term
indigenous for a person from the United States encompasses
American Indians and Alaska Natives. here are approxi-
mately 5.2 million reported indigenous Americans in the
United States, representing 1.7% of the population, including
those of more than one race [7]. he indigenous population
is younger than the nonindigenous population (30.3 years
compared to (cf.) 36.6 years, resp., [8]), and is varied with
566 federally recognized tribes [9]. hese tribal groups oten
have diferent histories, unique languages, and varied cultural
traditions, reside in numerous geographic regions, and show
various degrees of societal assimilation [10]. In 2010, the
majority (78%) of indigenous Americans lived outside of
native reservation areas [11].
3.4. Cardiovascular Disease. CVD covers all diseases and
conditions of the heart and blood vessels. Coronary heart
disease (CHD), stroke, heart failure, and peripheral vascular
disease contribute approximately 30% to the CVD burden in
developed countries [12]. In 2001, CVDwas the primary cause
of death worldwide, with indigenous peoples leading the way
[1].
3.4.1. Australia. CVD is the principal cause of death among
all ethnic groups in Australia [13]. he 2004-05 National
Aboriginal and Torres Strait Islander Health Survey (NAT-
SIHS, the largest health survey of Indigenous Australians,
[13]) found age-adjusted rates for CVD that were 30% higher
among the indigenous population (22%) compared to the
nonindigenous (17%) population, with CVD mortality three
times higher (27% cf. 9%, resp.). IndigenousAustralians show
a marked increase in the prevalence of CVD from around
35 years of age onwards, some 10 years earlier than in the
nonindigenous population.
3.4.2. New Zealand. Across all ethnic groups, CVDmortality
peaked between 1966 and 70, and since then, death rates
have fallen by over 60% in all age and sex groups [14, 15].
However, the decline has been slower among indigenous
New Zealanders. Between 1981 and 2004, CVD mortality
rates decreased by 43% among indigenous New Zealanders
compared to 65% among nonindigenous New Zealanders
[14, 15]. Indigenous New Zealanders continue to have a
higher prevalence of CVD compared to their nonindigenous
counterparts (7% cf. 4%, resp., [16]). Chan et al. [16] found
that CVD prevalence begins to rise ater age 35 years among
all age groups, but the rise in prevalence rate is greater among
indigenous New Zealanders.
3.4.3. United States. Among all ethnicities, CVD accounted
for 34% of all deaths in 2010 [17], 33% of which occurred
before the age of 75 years—well before the average life
expectancy of 78 years. According to the National Center
for Health Statistics (NCHS) [18], if all forms of major CVD
were eliminated, life expectancy would rise by almost 7
years. Despite a lower life expectancy and a slightly higher
prevalence of CVD among indigenous versus nonindigenous
Americans (23% cf. 21%), CVD mortality is lower (25%
cf. 34%) [17]. hese discrepant indings may be partially
explained by higher rates of mortality among indigenous
Americans for tuberculosis (600% higher), alcoholism (510%
higher), motor vehicle crashes (229% higher), diabetes (189%
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higher), unintentional injuries (152% higher), homicide (61%
higher), and suicide (62% higher) [19].
4. Modifiable Cardiometabolic Metabolic
Risk Factors
4.1. Obesity. Excess body fat increases the risk of developing
a range of health problems, including high blood pressure,
diabetes mellitus, and CVD [20–22]. According to results
from the FraminghamHeart Study [20], age-adjusted relative
risk for CVD is increased for overweight and obese men
(21% and 46%, resp.) and women (20% and 64%, resp.)
when compared with normal weight individuals. Population
studies, including those retrieved for the current paper,
typically estimate the proportion of people that are obese
by calculating an individual’s body mass index (BMI). BMI
is based on the assumption that the ratio between body
mass and height provides an indication of body fatness;
however, this oten discriminates against individuals (and/or
populations) that have a higher proportion of muscle mass.
Alternatively, waist circumference, waist-to-height ratio, and
waist-to-hip ratio (WHR) take into consideration body-fat
distribution, especially central (abdominal) obesity [23]. A
recent study compared the predictive power of BMI, waist
circumference, waist-to-height ratio, and WHR for diabetes
mellitus, hypertension, and dyslipidemia in Australian Abo-
riginal and Torres Strait Islander adults [24].WHRwas found
to have the greatest predictive power. A WHR of ≥0.90
and ≥0.80, for males and, females respectively, is considered
optimal. However, studies over the past two decades indicate
that the rate of risk for a given WHR difers between ethnic
groups; therefore these reference values should not be used to
ascertain absolute risk [25].
4.1.1. Australia. Ater adjusting for age diferences between
the two populations, the 2004/05 NATSIHS [13] reported
that indigenous Australians are 1.2 times more likely to be
overweight/obese than nonindigenous Australians (62% cf.
51%). In each age group, the disparity between indigenous
and nonindigenous groups was greater for females than for
males and wasmore pronounced within remote geographical
areas.
4.1.2. New Zealand. he 2006/07 New Zealand National
Health Survey (NZNHS) [26] reported that 36% of adults
were overweight and a further 27% were obese. he obesity
burden is particularly prevalent among indigenous New
Zealanders, with 42% of this population being obese com-
pared to 24% of their white counterparts [26]. However, there
was no signiicant increase reported for either ethnic group
between 2002/3 and 2006/07.
4.1.3. United States. An estimated 144,100,000 people or 66%
of the total US adult population is overweight or obese
[17].he rates of overweight/obesity are comparable between
indigenous andwhite Americans. However, while indigenous
Americans are less likely to be overweight (28%) than white
Americans (33%) they are more likely to be obese (42% cf.
31%, resp.). hese indings have been corroborated by other
studies [10].
4.2. Diabetes. Diabetes mellitus is a group of metabolic
diseases in which hyperglycaemia results from defective
insulin secretion, insulin action, or both [27, 28]. here
are several forms of diabetes mellitus, each with a diferent
cause and clinical history. he two most prominent forms
are type 1 and type 2 diabetes, which difer according to
their underlying pathophysiology, with type 1 oten attributed
to an autoimmune response and type 2 oten related to
several lifestyle factor. type 2 diabetes accounts for 90–95%
of diabetes cases and is a major risk factor for CVD [17, 29–
34]. Ameta-analysis [34], encompassing 6,573 subjects found
that type 2 diabetes resulted in greater CVD mortality risk
(RR 3.42, 95% CI: 2.23 to 5.23) than hypertension (RR 1.57,
95% CI: 1.10 to 2.24) or hypercholesteremia (RR 1.49, 95%
CI: 1.05 to 2.10). In turn, diabetes is modiied by lifestyle
factors, including physical inactivity and poor nutrition, in
addition to any genetic predisposition and the natural ageing
process [35–39]. Diabetes mellitus risk can be monitored by
measuring glucose tolerance or fasting blood glucose, where
a fasting blood glucose of <100mg/dL is considered optimal
[40].
4.2.1. Australia. he2007/08AustralianNationalHealth Sur-
vey [41] reported that an estimated 4% of the total population
had diagnosed diabetes. According to the 2004/05 NATSIHS
[13], the age-standardized prevalence of diabetes/elevated
blood glucose (i.e., prediabetes) among indigenous Aus-
tralians was 3.4 times the rate of that observed in nonindige-
nous people (12% cf. 4%). he prevalence of diabetes among
indigenous Australians increases rapidly ater 35 years of age,
rising from 10% at age 35–44 years to 32% at age 55 years and
over. By contrast, the prevalence increases from 2% to 12% for
nonindigenous people. Prevalence rates among indigenous
Australians are similar between genders, but those in remote
areas are almost twice as likely to have diabetes [13].
4.2.2. New Zealand. he 2006/07 NZNHS [26] reported 5%
of the total population was diagnosed with diabetes. Indige-
nous New Zealanders were twice as likely to be diagnosed
with diabetes (8% cf. 4%, resp.).here has been no signiicant
change in diabetes prevalence between 1996/97 and 2006/07
for both indigenous and nonindigenous populations or for
males and females [26].
4.2.3. United States. In 2006, an estimated 17,200,000 Amer-
icans had diagnosed diabetes, representing 8% of the adult
population [17]. A further estimated 6,100,000 had undiag-
nosed diabetes and 29% had prediabetes with abnormal fast-
ing glucose levels. Diabetes was once rare among indigenous
Americans, but the prevalence is rising dramatically with
rates almost twice as high when compared with their non-
Hispanic white counterparts (15% cf. 8%, resp.) [17].
Advances in Preventive Medicine 5
4.3. Cholesterol. he two most common blood lipids are
cholesterol and triglycerides. hese two blood fats are car-
ried on particles called lipoproteins, the most important of
which are low density lipoprotein (LDL) and high density
lipoprotein (HDL). Both carry cholesterol, but high levels
of LDL cholesterol have been shown to be atherogenic [42–
44]. Similarly, low levels of HDL cholesterol are associated
with increased CHD morbidity and mortality [45–47]. High
HDL cholesterol levels conversely convey reduced risk [45–
48]. In population studies, serum total cholesterol is oten
used as a surrogate for LDL cholesterol levels; however,
LDL concentrations confers more predictive value. he best
way to determine the true prevalence of high cholesterol
in the community is through blood samples [26]. An LDL
cholesterol level <100mg/dL is considered optimal [49].
4.3.1. Australia. he 2004/05 NATSIHS [13] found the preva-
lence of high age-adjusted serum total cholesterol levels to be
similar for indigenous (6%) and nonindigenous (7%) groups.
he same report found the prevalence of high total cholesterol
levels to drastically increase with age, starting at 4% for
both indigenous and nonindigenous groups when aged 35–
44 years, rising to 18% and 20%, respectively, aged 55 years or
over.
4.3.2. New Zealand. he 2006/07 NZNHS [26] reported
that 8% of the total adult (≥15 years) population were
currently taking medication for high cholesterol. Men (8%)
were signiicantly more likely than women (6%) to be tak-
ing medication for high cholesterol, when standardized for
age. Age-standardized cholesterol levels are similar between
indigenous and nonindigenous groups. However, the lack
of diferences in cholesterol between populations may be
misleading as the NZNHS data only details the number
of individuals on medication for high cholesterol, therefore
excluding those who remain undiagnosed.
4.3.3. United States. In 2006, an estimated 102,200,000 peo-
ple or 47% the total US adult population (≥20) had total
cholesterol levels above ≥200mg/dL, with an estimated 16%
registering a cholesterol level ≥240mg/dL [17]. he preva-
lence of high total cholesterol (≥240mg/dL) is substantially
greater for indigenous Americans compared to nonindige-
nous Americans (31% cf. 17%) [17].
4.4. Hypertension. Hypertension is a major risk factor for
CVD. For every 20mmHg systolic or 10mmHg diastolic
increase in resting blood pressure there is a twofold increase
in risk of death from ischemic heart disease or stroke
[50]. Hypertension is associated with shorter overall life
expectancy and earlier onset of CVD [51]. According to
the WHO, hypertension is likely the leading risk factor for
death worldwide [52]. In part, this is because hypertension
is common and because management of hypertension is
suboptimal [53]. An ideal blood pressure is onewith a systolic
pressure <120mmHg and a diastolic pressure <80mmHg
[40].
4.4.1. Australia. In 2004/05, hypertension was the most
commonly reported CVD condition among indigenous Aus-
tralians, with prevalence rates 50% greater than for non-
indigenous Australians when adjusted for age (10% cf. 15%,
resp.) [13]. Hypertension is of particular concern to remote
indigenous groups with an overall prevalence of 6% among
urban dwellers versus 10% for remote dwellers. For both
ethnic groups prevalence increases dramatically with age,
from 12 to 43% for indigenous and 4–33% for nonindigenous
groups between the ages 35–44 years and 55+ years, respec-
tively.
4.4.2. New Zealand. In 2006/07 one in seven adults (14%)
reported that they were currently taking medication for high
blood pressure [26]. Ater adjusting for age, indigenous New
Zealanders were 26% more likely to have elevated blood
pressure than the general population.
4.4.3. United States. Data from the 2006 National Health and
Nutrition Examination Survey (NHANES) [54] indicate that
34% of US adults over 20 years have hypertension. Rates of
hypertension are slightly lower among indigenous (30%) than
nonindigenous Americans (33%) [54].
5. Modifiable Lifestyle Risk Factors
5.1. Nutrition. Poor dietary habits afect multiple cardiovas-
cular risk factors including blood pressure, cholesterol levels,
glucose levels, and obesity [55–61]. A diet high in nutrient-
rich (vitamins, minerals, antioxidants and ibre) fruits and
vegetables can reduce the risk for many leading causes
of death [17, 55–57, 62]. In meta-analyses of prospective
cohort studies, each daily serving of fruits or vegetables was
associated with a 4% lower risk of CHD (RR 0.96, 95% CI:
0.93 to 0.99) and a 5% lower risk of stroke (RR: 0.95, 95% CI
0.92 to 0.97) [56, 57]. Five or more daily servings of fruits and
vegetables are recommended for optimal nutrition [17, 62].
Direct observation is considered the “gold standard” formon-
itoring dietary intake [63–65]. However, this approach can be
time consuming and impractical for use in large-scale studies.
Alternatively, a food frequency questionnaire (FFQ), includ-
ing the freely available National Cancer Institute Diet History
Questionnaire (http://riskfactor.cancer.gov/dhq2/) [66, 67],
allows for assessment of the usual patterns of food intake over
an extended period of time [68, 69] and is considerably less
burdensome in both time and cost than other measurement
tools [70, 71].
5.1.1. Australia. In 2004/05, 78% of the total Australian pop-
ulation consumed two or more servings of vegetables per day
compared with just 43% of the indigenous population [13].
Similarly, 53% of the total Australian population consumed
two or more servings of fruit compared with just 26% of
the indigenous population. Rates of consumption were also
reportedlymuch lower for indigenous groups living in remote
locations, wherein 20% reported no daily fruit intake and 15%
no daily vegetable intake.
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5.1.2. New Zealand. In 2006/07, two out of every three adults
(64%) consumed the recommended three ormore servings of
vegetables each day, and 60% consumed the recommended
two or more servings of fruits each day [26]. Consumption
of the recommended servings of vegetables and fruits was
higher for the nonindigenous (67% and 63%, resp.) than the
indigenous population (62% and 56%, resp.).
5.1.3. United States. Daily consumption of fruits and veg-
etables is poor across the general US population, with one
recent study [10] estimating that only 23% of the population
consume ive or more servings of fruits and vegetables per
day, with an even lower rate of consumption among the
indigenous population (18%). hese data are consistent with
other nutritional studies in indigenous communities [72–76].
5.2. Alcohol. Accumulating scientiic evidence indicates that
light to moderate alcohol consumption may signiicantly
reduce the risk of CVD and all-cause mortality [77–79].
However, excessive alcohol intake is toxic to both the heart
and overall health [77–79]. In particular, binge drinking,
even among otherwise light drinkers, increases cardiovas-
cular events and mortality [77–79]. Alcohol should not be
universally prescribed for health enhancement owing to
the lack of randomised outcome data and the potential
for developing irresponsible drinking habits. he American
Heart Association warns those who have never consumed
alcohol against initiating such behaviours due to the inability
to predict the potential for alcohol abuse [80]. Alcohol intake
can be monitored using a food frequency survey (FFQ) (see
above).
5.2.1. Australia. he 2004/05 NATSIHS [13] reported a lower
prevalence of alcohol consumption among indigenous (49%)
than nonindigenous (83%) Australians. However, ater stan-
dardizing for age, indigenous Australians are just as likely as
nonindigenous Australians (15% cf. 14%, resp.) to consume
higher than recommended daily intakes of alcohol (≥5
standard drinks/day for males and ≥4 standard drinks/day
for females). Increased alcohol consumption was reported to
be greatest among remote indigenous Australians (19%). For
both groups, the prevalence of high alcohol consumption had
risen by 3% since the previous (2001) NATSIHS.
5.2.2. New Zealand. In 2007/08, 85% of the New Zealand
population reported that they had consumed alcohol in the
past year, with a slightly higher rate among the nonindige-
nous (90%) than indigenous (85%) population [81]. However,
the indigenous population were twice as likely (24% cf. 12%,
resp.) to exhibit excessive alcohol consumption behaviours
(males: ≥6 standard drinks on one occasion; females: ≥4
standard drinks on one occasion).
5.2.3. United States. In 2006/07, a greater portion of the non-
Hispanic white population had consumed alcohol in the past
month compared to the indigenous population (55% cf. 60%,
resp.) [82]. However, a greater proportion of the indigenous
population consumed higher than the recommended levels of
alcohol consumption (≥5 standard drinks/day for ≥5 days in
the past 30 days) than the nonindigenous population (12% cf.
8%, resp.). It is important to note, however, that tribal diver-
sity has been reported for alcohol drinking tendency [83, 84].
Beals et al. [84] compared two culturally and geographically
distinct tribes and found that current drinking rates were
higher for a Northern Plains tribe than for a Southwest tribe.
Gender diferences have also been demonstrated, with May
and Gossage [85] reporting higher levels of binge drinking
among Northern tribe males than females (3 days cf. 1.3 days
of drinking ≥5 standard drinks in the past 30 days, resp.).
5.3. Physical Activity. It has been estimated that physical inac-
tivity is responsible for 12% of the global burden of myocar-
dial infarction [86]. Regular physical activity reduces CVD
risk in its own right and also improves CVD risk factors such
as obesity, hypertension, dyslipidemia, and type 2 diabetes
[87–92]. he American College of Sports Medicine (ACSM)
recommends at least 30 minutes of moderate-intensity phys-
ical activity (e.g., walking briskly, dancing, swimming, and
bicycling) at least 5 days a week [93]. A number of tools have
been developed to measure physical activity, ranging from
objectivemeasures, such as accelerometry, to subjective ques-
tionnaires [94]. While questionnaires are prone to technical
error, they are inexpensive and practical for use in population
studies and can provide information about physical activity
type and context [94]. he International Physical Activity
Questionnaire (IPAQ) (http://www.ipaq.ki.se/ipaq.htm) is a
freely available, cross-national monitoring tool which has
been validated for use in adults [95–99] and children [100–
103].
5.3.1. Australia. In 2004-05 an estimated one in three people
(33%) in Australia were sedentary, with an even higher
rate (51%) among the indigenous population [13]. Physical
inactivity contributes an estimated 7% of Australia’s disease
burden and 10% of all deaths [104] and accounts for 12%
of the health gap between indigenous and nonindigenous
Australians [105]. Despite the publicized importance of phys-
ical activity levels have remained stagnant in recent National
Health Surveys [5, 13].
5.3.2. New Zealand. In 2006/07, half of all adults reported
that they met physical activity guidelines (≥30mins/day on
most days), with 15% of all adults identiied as sedentary [26].
No signiicant diferences were reported between indigenous
andnonindigenous populations. For both ethnic groups,men
were more likely to be physically active than women (55%
cf. 48%, resp.), and for both groups physical activity levels
remained constant between 2002/03 and 2006/07 national
surveys. However, while similar physical activity levels have
been reported for indigenous and nonindigenous groups,
large-scale studies using validated instruments are limited.
henational surveys collect physical activity data using aNew
Zealand version of the IPAQ. Only one study has tested the
validity of the NZPAQ and reported poorer accuracy when
used on Ma¯ori and Pasiika compared to European/other
[106].
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5.3.3. United States. he 2007 US National Health Interview
Survey [107] estimated that 39% of all adults were seden-
tary, with a higher prevalence among women (41%) versus
men (37%). Compared to the nonindigenous population,
the indigenous population had a higher rate of sedentary
behaviour (40% cf. 37%, resp.) and a lower rate of meeting
prescribed physical activity (30min/day on most days) (10%
cf. 12%, resp.). hese data agree with other studies showing
lower rates of physical activity among indigenous Americans
compared to the general population [10, 108–113].
5.4. Tobacco Use. Cigarette smoking, which is estimated to
kill ive million people worldwide each year [117], has been
established as a risk factor for CVD since the 1940s [118].
he relationship between smoking andCVD is resultant upon
the interaction of multiple mechanisms which contribute to
atherosclerosis, vascular injury, vascular dysfunction, and
thrombosis, although these precise mechanisms are largely
unknown [119]. Cigarette smoking increases the incidence
of CVD in a dose-dependent manner [120–122], with even
occasional smoking increasing the risk of CVD [123]. Con-
versely, long-term prospective studies have demonstrated
considerablemortality risk reduction with smoking cessation
[124–126].
5.4.1. Australia. In 2004/05, an estimated one in ive people
(21%) in Australia were smoking cigarettes daily [13]. Among
the indigenous population, smoking rates are higher for those
living in remote (52%) versus nonremote (49%) areas and
particularly for males living in remote areas (58% for males
cf. 47% for females). For both ethnic groups, daily smoking
prevalence declined between 2001 and 2004/05, decreasing
from 49% to 46% and from 22% to 21% among indigenous
and nonindigenous populations, respectively.
5.4.2. New Zealand. In 2006/07, 20% of the New Zealand
population were current cigarette smokers, with a prevalence
rate that is twice as high among the indigenous (38%, age
adjusted) compared to the nonindigenous population [26].
Ater adjusting for age, indigenous women were more than
twice as likely to be smokers than women in the total
population, while indigenous men were 1.5 times more likely
to smoke than men in the total population.he prevalence of
smoking decreased from 23% in 2002/03 to 19% in 2006/07
among the total population and from 47% to 38% among the
indigenous population.
5.4.3. United States. Between 2000 and 2004, cigarette smok-
ing resulted in an estimated 443,000 premature deaths in
the US each year [127]. In adults aged 35 years or over,
33% of these deaths were related to CVD. From 1965 to
2007, smoking in the US declined by 50% among people
aged 18 years or over [128]. However, despite this progress,
in 2008 an estimated 21% of the total US population were
current cigarette smokers [107]. he prevalence of cigarette
smoking was higher among indigenous Americans at 23%,
increasing to 31% when mixed race indigenous Americans
were included. here also appear to be notable diferences
between tribes [10, 129, 130].
6. Discussion
here are more than 370 million indigenous people in 70
countries worldwide. Indigenous peoples are not monolithic;
there is signiicant variation between and within peoples
in terms of worldview, political forces, education, socioeco-
nomic status, living conditions, and familial factors.However,
many indigenous groups do share a striking commonality,
a discrepancy in life expectancy when compared to their
nonindigenous counterparts. hree such examples can be
seen in the life expectancy of indigenous groups in Australia,
New Zealand, and America. A higher prevalence of CVD
may be considered the driving force behind this discrepancy
[1], which is being fuelled by lifestyle and subsequent car-
diometabolic risk factors.
he indigenous populations from each of these nations
exhibit a cluster of cardiometabolic conditions. Compared
to their respective nonindigenous counterparts, all three
indigenous groups have higher rates of obesity and diabetes,
hypertension is greater for the indigenous populations ofNew
Zealand and Australia, and high cholesterol is greater among
indigenous groups in the United States. While each of these
conditions has independently been shown to accelerate CVD
[131–134], the efects are also thought to be additive [34]. Poor
lifestyle choices may precede and contribute to these car-
diometabolic outcomes. Compared to their nonindigenous
counterparts, all three indigenous groups exhibit higher rates
of smoking and dangerous alcohol behaviour, as well as lower
consumption of fruits and vegetables.he indigenous groups
of Australia and the United States also exhibit greater rates
of sedentary behaviour, while there remains a need to collect
valid physical activity data in New Zealand [106].
Holistic strategies, which recognize the complex inter-
actions between lifestyle factors, may assist in promoting
positive changes. For example, a recent systematic review and
meta-analysis [135] reported that physical activity interven-
tions have had only a small efect on children’s overall activity
levels.his implies that lifestyle strategies to promote physical
activity should be sensitive to total daily physical activity as
well as other lifestyle factors, including nutrition and sleep
behaviour, each of which may be inluenced by increased
physical activity levels and may afect cardiometabolic out-
comes [136, 137].
In order to maximize potential positive outcomes, strate-
gies which aim to promote positive changes in lifestyle should
not only be physiologically appropriate; they should also be
sensitive to sociocultural norms. For example, within Aus-
tralia an indigenous person’s connections to family, ancestors,
the wider community, and the land are very important to
the choices they make about all aspects of their lives [138].
Exercising alone for personal beneit may prevent a person
from spending time with family and loved ones, and this
may be seen as supericial. Similarly, the Ma¯ori people of
New Zealand show a decided preference for physical activ-
ities which involve whanaungatanga/kotahitanga (a team
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environment), a forum to experience feelings of whanau
(extended family) [139]. In this regard an argument can be
made that appropriate physical activity prescription can be
used as a vehicle to experience, discover, and reconnect to
indigenous cultural heritage [140]. However, it must also be
recognized that sociocultural norms may substantially difer
by group, including within a given nation. For example, in
the United States there are 566 federally recognized tribes
[9], with diferent histories, unique languages, varied cultural
traditions, and various degrees of societal assimilation [10].
Even within a given nation, strategies to promote lifestyle
changes must be speciic to a group, not to the population
as a whole, especially when a geographical area includes
diferent language and culturally distinct groups [141]. Diver-
sity competence involves knowledge, skills, and abilities that
enable a researcher to deal with a speciic population. he
National Standards for Culturally and Linguistically Appropri-
ate Services in Health and Health Care (the National CLAS
Standards) [142] in the United States intend to advance
health equity, improve quality, and help eliminate health
care disparities by providing a blueprint for individuals and
health and health care organizations to implement culturally
and linguistically appropriate services. Adoption of these
standards is highly recommended for health care providers
interested in respecting such diversity competences.
7. Limitations
To ensure reliable comparisons between ethnic groups, the
largest data sources available were utilized for a given cohort
(nation), where available. Wherever large data sets were not
available, reliable sets of relevant data were used to consoli-
date thought and formulate a comprehensive picture. All data
used in the current publication spanned from 2002 to 2012.
his would have introduced selection and methodological
and historical bias, limiting our ability to make accurate
comparisons across nations. Furthermore, the preponder-
ance of the literature on the health of indigenous populations
is focused on describing or understanding problems [143],
rather than on testing the efectiveness of potential solutions.
Further studies are required to determine causality between
lifestyle and cardiometabolic risk factors and to determine
whether causality is moderated by ethnicity.
8. Implications
his review has described the relationship between common
lifestyle choices, cardiometabolic conditions (i.e., lifestyle-
related disease), and CVD. It is evident that disparities
in CVD prevalence, mortality, and associated risk factors
exist between indigenous and nonindigenous populations.
Causality, however, has yet to be conclusively determined
and is essential if we are to develop efective solutions for
decreasing disease burden in a number of groups. While
the described model will assist future research focusing on
indigenous health outcomes, it must also be recognised that
such research must be sensitive to diferences in culture
between indigenous groups within a country, in addition to
being sensitive to national cultural norms.
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